Esperion Therapeutics Stock News

Esperion Therapeutics Inc. (ESPR) shares closed today at 0.5% above its 52 week low of $4.13, giving the company a market cap of $120M. The stock is currently down 17.0% year-to-date, down 86.6% over the past 12 months, and down 69.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 29.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 11.5% lower than its 5-day moving average, 17.0% lower than its 20-day moving average, and 52.8% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 164.6% The company's stock price performance over the past 12 months lags the peer average by 1594.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Esperion Therapeutics Inc. (ESPR) shares closed today at 1.4% above its 52 week low of $4.85, giving the company a market cap of $143M. The stock is currently down 81.1% year-to-date, down 82.3% over the past 12 months, and down 60.7% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 56.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1285.8% The company's stock price performance over the past 12 months lags the peer average by -2295.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Wall Street analysts forecast that Esperion Therapeutics, Inc. (NASDAQ:ESPR) will report earnings per share of ($2.74) for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Esperion Therapeutics earnings, with the highest EPS estimate coming in at ($2.33) and the lowest estimate coming in at ($3.06). Esperion Therapeutics posted earnings per []

Esperion Therapeutics Inc. (NASDAQ:ESPR) has a beta value of 0.85 and has seen 1.2 million shares traded in the last trading session. The company, currently valued at $317.65M, closed the last trade at $5.16 per share which meant it lost -$0.03 on the day or -0.58% during that session. The ESPR stock price is -665.31% Esperion Therapeutics Inc. (ESPR) Is Down -0.58%, As Bears Mark A Loss Read More »

Esperion Therapeutics Inc. (NASDAQ:ESPR) shares, rose in value on Wednesday, 12/15/21, with the stock price up by 6.57% to the previous days close as strong demand from buyers drove the stock to $5.35. Actively observing the price movement in the last trading, the stock closed the session at $5.02, falling within a range of $4.85 Understanding Esperion Therapeutics Inc. (NASDAQ: ESPR)s Growth Potential Read More »

Esperion Therapeutics, Inc. (NASDAQ:ESPR) saw unusually large options trading on Friday. Traders acquired 3,964 call options on the stock. This represents an increase of approximately 446% compared to the average daily volume of 726 call options. Large investors have recently added to or reduced their stakes in the business. Marshall Wace LLP purchased a new []

Esperion Therapeutics, Inc. (NASDAQ:ESPR) has earned an average recommendation of Hold from the eleven research firms that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to []

Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) have received an average recommendation of Hold from the eleven ratings firms that are currently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating, five have issued a hold rating, two have given a buy rating and one has assigned a strong []

NEW YORK , Dec. 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DIDI, EDU, LGVN, CCL, and ESPR. Full story available on Benzinga.com

Esperion Therapeutics Inc (NASDAQ: ESPR ) priced its previously announced underwritten public offering of 32.14 million shares and short-term warrants to purchase up to 32.14 million shares at $7/share and accompanying warrant . The short-term warrants have an exercise price of $9.00 per share, are exercisable immediately, and will expire two years following the date of Full story available on Benzinga.com

Esperion Therapeutics Inc (NASDAQ: ESPR) priced its previously announced underwritten public offering of 32.14 million shares and short-term warrants to purchase up to 32.14 million shares at $7/sha

The stock price of Esperion Therapeutics Inc (NASDAQ: ESPR) fell by over 30% pre-market today. This is why it happened.

Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock?

The moving averages on the daily timeframe suggest a bearishness in price, as the 20, 50, 100 and 200 are all in a bearish alignment -- meaning the shorter duration moving averages are below the longer duration averages, implying a stable downward trend. The post Esperion Therapeutics Inc (ESPR): Price Down $-0.11 (-1.41)% Over Past Day, Down $-0.15 (-1.92)% Over Past Hour appeared first on ETF Daily News .